The vatican meeting on neuroprotection for Parkinson's disease
Mov Disord
.
2013 Jan;28(1):1-2.
doi: 10.1002/mds.25356.
Authors
C Warren Olanow
1
,
Jose A Obeso
,
Fabrizio Stocchi
Affiliation
1
Department of Neurology, Mount Sinai School of Medicine, New York, New York 10029, USA.
[email protected]
PMID:
23390093
DOI:
10.1002/mds.25356
No abstract available
Publication types
Introductory Journal Article
MeSH terms
Humans
Neuroprotective Agents / therapeutic use*
Parkinson Disease / therapy*
Vatican City
Substances
Neuroprotective Agents